Andrea Tan Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Andrea Tan

Stock Analyst at Goldman Sachs

(3.55)
# 2632
Out of 5,506 analysts
55
Total ratings
Success rate
Average return

16 Stocks

Name Action PT Current % Upside Ratings Updated
INSM Insmed
Maintains: Strong Buy
121 196
157.16 24.71% 12 Oct 3, 2025
IOVA Iovance Biotherapeut...
Maintains: Buy
16 8
2.34 241.88% 7 May 12, 2025
TARS Tarsus Pharmaceutica...
Maintains: Neutral
46 51
65.17 -21.74% 4 May 5, 2025
DAWN Day One Biopharmaceu...
Maintains: Buy
39 27
7.95 239.62% 6 Mar 25, 2025
SGMT Sagimet Biosciences
Maintains: Neutral
23 6
7.29 -17.7% 5 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
31
36.12 -14.17% 1 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
3 2
2.32 -13.79% 3 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Sell
2
15.06 -86.72% 1 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
17
n/a n/a 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
183.36 -12.74% 1 Nov 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
27 24
5.9 306.78% 2 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
10 4
1.21 230.58% 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
178 375
443.01 -15.35% 1 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
13
n/a n/a 1 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
n/a n/a 6 Nov 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
120 80
37.46 113.56% 2 May 24, 2022